March 11, 2011. The day that the world lost its words and experienced sadness and despair from the unprecedented disaster. The factory of Aska Pharmaceutical, located in Iwaki City, Fukushima Prefecture, was also largely devastated. Due to continuing significant aftershocks and the threat of invisible radioactivity, distribution and transportation facilities were paralyzed, and everyone should have been prepared to suspend production at the factory. However, it could be a matter of life and death for patients with hypothyroidism who needed the drug manufactured by Aska Pharmaceutical. This was because Aska Pharmaceutical accounted for 98% of Japan’s total share of this therapeutic drug. While a lot of conflicting information was communicated, immediately after the earthquake disaster, the client had already been staying at the factory day and night and making every effort to investigate the factory and procure raw materials for restarting production. While we were preparing for the end of the world, the client had coped with the earthquake disaster and had already taken new steps. In addition, the client planned a project for a quality control building as evidence of reconstruction, and fortunately for us, we were contracted for the design. As we were deeply impressed with the attitude of the client, we did not propose a closed quality control building as used by other companies, but open facilities in which the stakeholders of Aska Pharmaceutical could realize the reconstruction when visiting this place. Currently, the PIC/S GMP standards are becoming global standards; therefore, it is imperative to establish a more stringent quality control system. To respond to these circumstances, we aimed to provide a QC/QA laboratory with facilities having cutting-edge equipment in place and architecture of maximum transparency to positively expose researchers working actively.
|Structure Design||Showa Sekkei|